SCHEMBL22927248

SCHEMBL22927248

N=Cc1ccccc1Nc1cccc(O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.55
TSHR P16473 1/20 0.55
BRAF P15056 4/20 0.47
HDAC6 Q9UBN7 1/20 0.46
KMT2A Q03164 6/20 0.45
RAPGEF4 Q8WZA2 1/20 0.44
MEN1 O00255 4/20 0.43
POLB P06746 1/20 0.43
RAD52 P43351 1/20 0.43
GFER P55789 1/20 0.43
AURKA O14965 1/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
SRC P12931 1/20 0.42
ACVR1 Q04771 1/20 0.42
PTK6 Q13882 1/20 0.42
ALK Q9UM73 1/20 0.42
AURKC Q9UQB9 1/20 0.42
MAPT P10636 5/20 0.41
ALDH1A1 P00352 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22927246 0.82 BRAF (0.50) CYP3A4TSHRBRAFKMT2AMEN1
SCHEMBL1920770 0.82 CYP3A4 (0.72) CYP3A4TSHRBRAFHDAC6KMT2A
SCHEMBL20180549 0.80 EGFR (0.47) KMT2ARAPGEF4MEN1EGFRALDH1A1
SCHEMBL19250123 0.80 NPSR1 (0.55) CYP3A4KMT2AMEN1EGFRMAPT
SCHEMBL29940289 0.80 MAPT (0.50) CYP3A4TSHRKMT2AMEN1GFER
SCHEMBL28039419 0.77 CYP3A4 (0.64) CYP3A4TSHRBRAFHDAC6KMT2A
SCHEMBL3234606 0.74 RAPGEF4 (0.61) CYP3A4TSHRBRAFHDAC6KMT2A
SCHEMBL3225644 0.74 CYP3A4 (0.60) CYP3A4TSHRBRAFHDAC6KMT2A
SCHEMBL9559159 0.74 MAPT (0.62) CYP3A4TSHRBRAFHDAC6KMT2A
SCHEMBL1389429 0.73 CYP3A4 (0.86) CYP3A4TSHRBRAFHDAC6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230115701-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES UNIV ARIZONA STATE (US) 2023-04-13 US disclosed
US-20210024559-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES UNIV ARIZONA STATE (US) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230115701-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES PAICS, DNTT, PNPO CYP3A4 1105/4885TSHR 2799/4885BRAF 4816/4885
US-20210024559-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES PAICS, DNTT, PNPO CYP3A4 1105/4885TSHR 2799/4885BRAF 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.